rebel Financial rebel Financial
← All Posts
APGE

Apogee Therapeutics, Inc.

June 10, 2026 • Author: Phil Ratcliff • APGE
Item Proposal Vote
1 Election of Class lll Directors for terms expiring in 2029
1.01 Mark C. McKenna ✓ For
1.02 Jennifer Fox ✓ For
1.03 William (BJ) Jones, Jr. ✓ For
2 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. ✓ For
3 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. ✓ For
Attachments
📄
APGE_ANNUAL_REPORT_2025.pdf 3.9 MB
📄
APGE_PROXY_STATEMENT.pdf 2.9 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.